Schedule 13G ownership disclosure

ITERUM THERAPEUTICS PLC

Security class unavailable · CUSIP: G6333L200

Event date: 2024-01-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
850,000
Percent of class
6.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-24-000843
Form type
SC 13G
Filer
Iterum Therapeutics plc
CIK
CIK 1659323
Filed
Jan 31, 2024
Reporting period
Jan 30, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub